{"id":32018,"date":"2025-04-18T14:36:45","date_gmt":"2025-04-18T06:36:45","guid":{"rendered":"https:\/\/flcube.com\/?p=32018"},"modified":"2025-04-18T14:36:46","modified_gmt":"2025-04-18T06:36:46","slug":"junion-therapeutics-secures-rmb-100-million-series-a-financing-for-weight-loss-device","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=32018","title":{"rendered":"Junion Therapeutics Secures RMB 100 Million Series A Financing for Weight Loss Device"},"content":{"rendered":"\n<p>China-based Junion Therapeutics (Xiamen) Co., Ltd has reportedly secured RMB 100 million (USD 13.7 million) in a Series A financing round. The funding was co-led by Zhangzhou State-owned Capital Operation Group and Guoxing Investment, with additional participation from Pianzhaihuang Investment, Xiamen Strait Venture Capital, China Reform Securities Capital, and returning investor Yingke PE. The proceeds will be allocated toward regulatory filing, manufacturing, and marketing of the company&#8217;s first oral weight loss device, as well as accelerating the development of its product pipelines across multiple core innovative drug-device combination technology platforms.<\/p>\n\n\n\n<p><strong>Funding and Strategic Allocation<\/strong><br>The capital raised will play a pivotal role in advancing Junion Therapeutics&#8217; innovative oral weight loss device through the stages of regulatory approval, production, and market launch. Moreover, the funds will be instrumental in fast-tracking the development of the company&#8217;s diverse product pipelines, which leverage cutting-edge drug-device combination technologies. This strategic financial allocation underscores Junion&#8217;s commitment to innovation and its dedication to addressing unmet medical needs in the weight management space.<\/p>\n\n\n\n<p><strong>Investor Collaboration<\/strong><br>The participation of a consortium of investors, including state-owned entities and private equity firms, highlights the confidence in Junion Therapeutics&#8217; technology and market potential. Their collective investment not only provides financial backing but also brings a wealth of industry expertise and resources that will support the company&#8217;s growth and commercialization efforts.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China-based Junion Therapeutics (Xiamen) Co., Ltd has reportedly secured RMB 100 million (USD 13.7 million)&#8230;<\/p>\n","protected":false},"author":1,"featured_media":32020,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10,22],"tags":[20,4012],"class_list":["post-32018","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","category-medical-device","tag-finance","tag-junion-therapeutics"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Junion Therapeutics Secures RMB 100 Million Series A Financing for Weight Loss Device - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China-based Junion Therapeutics (Xiamen) Co., Ltd has reportedly secured RMB 100 million (USD 13.7 million) in a Series A financing round. The funding was co-led by Zhangzhou State-owned Capital Operation Group and Guoxing Investment, with additional participation from Pianzhaihuang Investment, Xiamen Strait Venture Capital, China Reform Securities Capital, and returning investor Yingke PE. The proceeds will be allocated toward regulatory filing, manufacturing, and marketing of the company&#039;s first oral weight loss device, as well as accelerating the development of its product pipelines across multiple core innovative drug-device combination technology platforms.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=32018\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Junion Therapeutics Secures RMB 100 Million Series A Financing for Weight Loss Device\" \/>\n<meta property=\"og:description\" content=\"China-based Junion Therapeutics (Xiamen) Co., Ltd has reportedly secured RMB 100 million (USD 13.7 million) in a Series A financing round. The funding was co-led by Zhangzhou State-owned Capital Operation Group and Guoxing Investment, with additional participation from Pianzhaihuang Investment, Xiamen Strait Venture Capital, China Reform Securities Capital, and returning investor Yingke PE. The proceeds will be allocated toward regulatory filing, manufacturing, and marketing of the company&#039;s first oral weight loss device, as well as accelerating the development of its product pipelines across multiple core innovative drug-device combination technology platforms.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=32018\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-18T06:36:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-18T06:36:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1806.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32018#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32018\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Junion Therapeutics Secures RMB 100 Million Series A Financing for Weight Loss Device\",\"datePublished\":\"2025-04-18T06:36:45+00:00\",\"dateModified\":\"2025-04-18T06:36:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32018\"},\"wordCount\":236,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32018#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/1806.webp\",\"keywords\":[\"Finance\",\"Junion Therapeutics\"],\"articleSection\":[\"Company\",\"Deals\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=32018#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32018\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=32018\",\"name\":\"Junion Therapeutics Secures RMB 100 Million Series A Financing for Weight Loss Device - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32018#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32018#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/1806.webp\",\"datePublished\":\"2025-04-18T06:36:45+00:00\",\"dateModified\":\"2025-04-18T06:36:46+00:00\",\"description\":\"China-based Junion Therapeutics (Xiamen) Co., Ltd has reportedly secured RMB 100 million (USD 13.7 million) in a Series A financing round. The funding was co-led by Zhangzhou State-owned Capital Operation Group and Guoxing Investment, with additional participation from Pianzhaihuang Investment, Xiamen Strait Venture Capital, China Reform Securities Capital, and returning investor Yingke PE. The proceeds will be allocated toward regulatory filing, manufacturing, and marketing of the company's first oral weight loss device, as well as accelerating the development of its product pipelines across multiple core innovative drug-device combination technology platforms.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32018#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=32018\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32018#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/1806.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/1806.webp\",\"width\":1080,\"height\":608,\"caption\":\"Junion Therapeutics Secures RMB 100 Million Series A Financing for Weight Loss Device\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32018#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Junion Therapeutics Secures RMB 100 Million Series A Financing for Weight Loss Device\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Junion Therapeutics Secures RMB 100 Million Series A Financing for Weight Loss Device - Insight, China&#039;s Pharmaceutical Industry","description":"China-based Junion Therapeutics (Xiamen) Co., Ltd has reportedly secured RMB 100 million (USD 13.7 million) in a Series A financing round. The funding was co-led by Zhangzhou State-owned Capital Operation Group and Guoxing Investment, with additional participation from Pianzhaihuang Investment, Xiamen Strait Venture Capital, China Reform Securities Capital, and returning investor Yingke PE. The proceeds will be allocated toward regulatory filing, manufacturing, and marketing of the company's first oral weight loss device, as well as accelerating the development of its product pipelines across multiple core innovative drug-device combination technology platforms.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=32018","og_locale":"en_US","og_type":"article","og_title":"Junion Therapeutics Secures RMB 100 Million Series A Financing for Weight Loss Device","og_description":"China-based Junion Therapeutics (Xiamen) Co., Ltd has reportedly secured RMB 100 million (USD 13.7 million) in a Series A financing round. The funding was co-led by Zhangzhou State-owned Capital Operation Group and Guoxing Investment, with additional participation from Pianzhaihuang Investment, Xiamen Strait Venture Capital, China Reform Securities Capital, and returning investor Yingke PE. The proceeds will be allocated toward regulatory filing, manufacturing, and marketing of the company's first oral weight loss device, as well as accelerating the development of its product pipelines across multiple core innovative drug-device combination technology platforms.","og_url":"https:\/\/flcube.com\/?p=32018","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-04-18T06:36:45+00:00","article_modified_time":"2025-04-18T06:36:46+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1806.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=32018#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=32018"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Junion Therapeutics Secures RMB 100 Million Series A Financing for Weight Loss Device","datePublished":"2025-04-18T06:36:45+00:00","dateModified":"2025-04-18T06:36:46+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=32018"},"wordCount":236,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=32018#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1806.webp","keywords":["Finance","Junion Therapeutics"],"articleSection":["Company","Deals","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=32018#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=32018","url":"https:\/\/flcube.com\/?p=32018","name":"Junion Therapeutics Secures RMB 100 Million Series A Financing for Weight Loss Device - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=32018#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=32018#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1806.webp","datePublished":"2025-04-18T06:36:45+00:00","dateModified":"2025-04-18T06:36:46+00:00","description":"China-based Junion Therapeutics (Xiamen) Co., Ltd has reportedly secured RMB 100 million (USD 13.7 million) in a Series A financing round. The funding was co-led by Zhangzhou State-owned Capital Operation Group and Guoxing Investment, with additional participation from Pianzhaihuang Investment, Xiamen Strait Venture Capital, China Reform Securities Capital, and returning investor Yingke PE. The proceeds will be allocated toward regulatory filing, manufacturing, and marketing of the company's first oral weight loss device, as well as accelerating the development of its product pipelines across multiple core innovative drug-device combination technology platforms.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=32018#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=32018"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=32018#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1806.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1806.webp","width":1080,"height":608,"caption":"Junion Therapeutics Secures RMB 100 Million Series A Financing for Weight Loss Device"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=32018#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Junion Therapeutics Secures RMB 100 Million Series A Financing for Weight Loss Device"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1806.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/32018","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=32018"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/32018\/revisions"}],"predecessor-version":[{"id":32021,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/32018\/revisions\/32021"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/32020"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=32018"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=32018"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=32018"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}